Grey supports Pfizer with Exubera launch
The pharmaceutical company Pfizer has commissioned the Zurich-based advertising agency Grey to handle the launch of Exubera in Switzerland.
The pharmaceutical company Pfizer has commissioned Grey Global Group with the worldwide launch of Exubera, the first insulin to be inhaled for the treatment of diabetes. For the market launch in Switzerland, Pfizer is being supported by the Zurich-based advertising agency Grey. While Exubera has been on the market in Germany for several weeks and will be available to patients in America in July, the drug is currently still being reviewed by Swissmedic in Switzerland.
